These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 36910613)
1. Editorial: Critical complications in pediatric oncology and hematopoietic cell transplant - how far we have come and how much further we must go. Agulnik A; Mahadeo KM; Steiner ME; McArthur JA Front Oncol; 2023; 13():1148321. PubMed ID: 36910613 [No Abstract] [Full Text] [Related]
2. Extracorporeal Membrane Oxygenation Candidacy in Pediatric Patients Treated With Hematopoietic Stem Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy: An International Survey. Ghafoor S; Fan K; Di Nardo M; Talleur AC; Saini A; Potera RM; Lehmann L; Annich G; Wang F; McArthur J; Sandhu H Front Oncol; 2021; 11():798236. PubMed ID: 35004323 [TBL] [Abstract][Full Text] [Related]
9. Chimeric Antigen Receptor T-Cell Therapy Clinical Results in Pediatric and Young Adult B-ALL. DiNofia AM; Maude SL Hemasphere; 2019 Aug; 3(4):e279. PubMed ID: 31723849 [TBL] [Abstract][Full Text] [Related]
10. Exploring the Dilemma of Allogeneic Hematopoietic Cell Transplantation after Chimeric Antigen Receptor T Cell Therapy: To Transplant or Not? Bouziana S; Bouzianas D Biol Blood Marrow Transplant; 2020 Aug; 26(8):e183-e191. PubMed ID: 32304874 [TBL] [Abstract][Full Text] [Related]
11. How close are we to CAR T-cell therapy for AML? Gill SI Best Pract Res Clin Haematol; 2019 Dec; 32(4):101104. PubMed ID: 31779970 [TBL] [Abstract][Full Text] [Related]
12. Immunization practices in acute lymphocytic leukemia and post-hematopoietic stem cell transplant in Canadian Pediatric Hematology/Oncology centers. Top KA; Pham-Huy A; Price V; Sung L; Tran D; Vaudry W; Halperin SA; De Serres G Hum Vaccin Immunother; 2016 Apr; 12(4):931-6. PubMed ID: 26962702 [TBL] [Abstract][Full Text] [Related]
13. CAR T-cells: hot news in cancer therapy. Hrabovský Š Vnitr Lek; 2020; 66(7):420-424. PubMed ID: 33380120 [TBL] [Abstract][Full Text] [Related]
14. Incorporating a clinical oncology pharmacist into an ambulatory care pharmacy in pediatric hematology-oncology and transplant clinic: Assessment and significance. Ali K; Al-Quteimat O; Naseem R; Malhi SM; Wajdi M; Jahan N; Ansari SH; Shamsi TS J Oncol Pharm Pract; 2021 Jun; 27(4):815-820. PubMed ID: 32633660 [TBL] [Abstract][Full Text] [Related]
15. Immunotherapies Old and New: Hematopoietic Stem Cell Transplant, Chimeric Antigen Receptor T Cells, and Bispecific Antibodies for the Treatment of Relapsed/Refractory Diffuse Large B Cell Lymphoma. Doraiswamy A; Shah MR; Bannerji R Curr Hematol Malig Rep; 2021 Feb; 16(1):72-81. PubMed ID: 33619641 [TBL] [Abstract][Full Text] [Related]
16. Hematopoietic Cell Transplantation after CD19 Chimeric Antigen Receptor T Cell-Induced Acute Lymphoblastic Lymphoma Remission Confers a Leukemia-Free Survival Advantage. Summers C; Wu QV; Annesley C; Bleakley M; Dahlberg A; Narayanaswamy P; Huang W; Voutsinas J; Brand A; Leisenring W; Jensen MC; Park JR; Gardner RA Transplant Cell Ther; 2022 Jan; 28(1):21-29. PubMed ID: 34644605 [TBL] [Abstract][Full Text] [Related]
17. Is There Still a Role for Transplant for Patients with Mantle Cell Lymphoma (MCL) in the Era of CAR-T Cell Therapy? Beitinjaneh A; Kaufman A; Wang Y; Jain P; Srour SA; Wang M Curr Treat Options Oncol; 2022 Nov; 23(11):1614-1625. PubMed ID: 36227407 [TBL] [Abstract][Full Text] [Related]
18. Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study. Zhao H; Wei J; Wei G; Luo Y; Shi J; Cui Q; Zhao M; Liang A; Zhang Q; Yang J; Li X; Chen J; Song X; Jing H; Li Y; Hao S; Wu W; Tan Y; Yu J; Zhao Y; Lai X; Yin ETS; Wei Y; Li P; Huang J; Wang T; Blaise D; Xiao L; Chang AH; Nagler A; Mohty M; Huang H; Hu Y J Hematol Oncol; 2020 May; 13(1):42. PubMed ID: 32366260 [TBL] [Abstract][Full Text] [Related]
19. Challenges and Prospects of Chimeric Antigen Receptor T-cell Therapy for Metastatic Prostate Cancer. Gorchakov AA; Kulemzin SV; Kochneva GV; Taranin AV Eur Urol; 2020 Mar; 77(3):299-308. PubMed ID: 31471138 [TBL] [Abstract][Full Text] [Related]